Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C19H27NO |
Molar mass | 285.431 g·mol−1 |
3D model (JSmol) | |
| |
|
TH-PVP is a substituted cathinone derivative which has been sold as a designer drug. It was first identified by a forensic laboratory in Hungary in 2015,[1] but has subsequently been found in numerous other countries around the world including Spain, Belgium, Poland, Turkey and Brazil.[2][3][4][5][6][7] Pharmacological studies in vitro showed it to inhibit reuptake and promote the release of monoamine neurotransmitters with some selectivity for serotonin,[8] but it failed to produce stimulant effects in animals,[9] and has a pharmacological profile more comparable to that of sedating empathogens such as MDAI and 5-Methyl-MDA.